Skip to main content
. 2024 Apr 15;16(4):1268–1280. doi: 10.4251/wjgo.v16.i4.1268

Figure 3.

Figure 3

Kaplan-Meier analysis of progression-free survival and overall survival of patients in the two groups. A: Progression-free survival; B: Overall survival. PFS: Progression-free survival; OS: Overall survival; irAEs: Immune-related adverse reactions.